AP2 | Early Access post-MA
Early Access post-MA AP2 (Early Access post-MA) enables patients to [...]
ASMR | Added therapeutic value
Added therapeutic benefit of a new treatment compared with standard [...]
ATMPs | Advanced Therapy Medicinal Products
Advanced therapy medicinal products (cell, gene, tissue-based) Advanced Therapy Medicinal [...]
ATU de Cohorte | Cohort Temporary Authorisation
Temporary authorisation granted for a cohort of patients with the [...]
ATU Nominative | Nominative Temporary Authorisation
Temporary authorisation granted for an individual patient on physician request [...]
CAT | Committee for Advanced Therapies
EMA’s Committee for Advanced Therapies The Committee for Advanced Therapies [...]
CEPS | French Health Economic Committee
Economic Committee for Health Products The Economic Committee for Health [...]
CHMP | Committee for Medicinal Products for Human Use
EMA Committee for Medicinal Products for Human Use The Committee [...]
CMA | Conditional Marketing Authorisation
Conditional Marketing Authorisation requiring further data Conditional Marketing Authorisation (CMA) [...]
CMS | Concerned Member State
Concerned Member State in an EU authorisation procedure. In decentralised [...]
